JTO Clinical and Research Reports

Corrigendum to “Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC [JTO Clinical and Research Reports Vol. 4 No. 1: 100431]

Pub Date : 2025-10-01 DOI: 10.1016/j.jtocrr.2025.100892 Marina C. Garassino MD , Shirish Gadgeel MD , Silvia Novello MD, PhD , Balazs Halmos MD , Enriqueta Felip MD , Giovanna Speranza MD , Rina Hui PhD , Edward B. Garon MD , Hidehito Horinouchi MD, PhD , Shunichi Sugawara MD, PhD , Delvys Rodriguez-Abreu MD, PhD , Martin Reck MD , Razvan Cristescu PhD , Deepti Aurora-Garg PhD , Andrey Loboda PhD , Jared Lunceford PhD , Julie Kobie PhD , Mark Ayers MS , Bilal Piperdi MD , M. Catherine Pietanza MD , Luis Paz-Ares MD, PhD

Durable Response to Lenvatinib in Platinum-Refractory Metastatic High-Grade Thymic Mucoepidermoid Carcinoma: A Case Report

Pub Date : 2025-10-01 DOI: 10.1016/j.jtocrr.2025.100894 Noa Amin PhD, MRCP , Thanika Ketpueak DM , Simon Jordan MBBCh, MD , Andrew G. Nicholson DM, FRCPath , Yu Zhi Zhang MBBS, PhD, FRCPath , Sanjay Popat PhD FRCP

Provider Behavioral Determinants and Preferences for Lung Cancer Screening Implementation: A Brief Report

Pub Date : 2025-09-17 DOI: 10.1016/j.jtocrr.2025.100905 Jennifer A. Lewis MD, MS, MPH , Lauren R. Samuels PhD , Lucy B. Spalluto MD, MPH , Christopher Lindsell PhD , Claudia I. Henschke PhD, MD , David F. Yankelevitz MD , Carol Callaway-Lane DNP, ACNP-BC , Robert S. Dittus MD, MPH , Hilary A. Tindle MD, MPH , Renda Soylemez Wiener MD, MPH , Christopher G. Slatore MD, MS , Drew Moghanaki MD, MPH , Carolyn M. Audet PhD , Christianne L. Roumie MD, MPH